Article · 20 May 2025
Review articlePublished 21 Jul 2016
Pharmacotherapy of obesity
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Obesity is a major health problem with significant comorbidities. Its prevalence has dramatically increased over the last few decades, so that it is considered an international epidemic. Large epidemiologic studies have clearly associated obesity with cardiovascular disease and side effects in almost every organ system, so that the need for treatment appears to be imperative. Several short- and, recently, long-term anti-obesity drugs have been evaluated, but so far there is no ‘magic pill’ that could permanently cure or control obesity, although a number produce significant health benefits from a medical point of view. Orlistat, sibutramine and rimonabant are the most widely used anti-obesity drugs in clinical practice, while new, much more promising ones will be in the market in the following few years.
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Clinical Practice.
Article · 20 May 2025
Histological effects of doxorubicin and baobab plants on some organs of rat
Article · 28 Mar 2025
Using
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Practice
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Kostas Lois”
- BylineArticles whose byline prints “Sudhesh Kumar”